# CLOMIPHENE CITRATE
> **ANDA216545** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON · Approved 2024-11-12
## Drug
- **FDA Application Number:** ANDA216545
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOMIPHENE CITRATE
- **Generic name:** CLOMIPHENE CITRATE
- **Active ingredients:** CLOMIPHENE CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON
- **Manufacturer:** Advagen Pharma Ltd
- **First approval:** 2024-11-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216545)
---
*MORVS · CC0 1.0*